Globus Medical Reports Third Quarter 2024 Results

AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024. Worldwide net sales were $625.7 million, an increase of 63.1$51.8 millionGAAP diluted earnings per share (“EPS”) was $0.38 and non-GAAP diluted EPS was$0.83Non-GAAP adjusted EBITDA was $193.7 million, or 31.0% of net sales “Our third quarter results reflect the endu ...